Oncolytics Biotech Inc.

NasdaqCM:ONCY Stock Report

Market Cap: US$103.8m

Oncolytics Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:ONCY Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Aug 25BuyUS$20,281Jared KellyIndividual23,500US$0.86
17 Jul 25BuyUS$5,722Allison HagermanIndividual4,600US$1.24
17 Jul 25BuyUS$19,050Thomas HeinemanIndividual15,000US$1.27
16 Jul 25BuyUS$60,062Jared KellyIndividual50,400US$1.19
15 Jul 25BuyUS$30,238Andrew AromandoIndividual25,500US$1.19
15 Jul 25BuyUS$14,976Kirk LookIndividual12,800US$1.17

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ONCY?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,054,7831.91%
Institutions2,820,1982.62%
General Public102,731,39595.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 39.6%.

Top Shareholders

Top 25 shareholders own 3.93% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.43%
Wayne Pisano
462,414US$446.2k79%no data
0.36%
Morgan Stanley
383,346US$369.9k1,930%no data
0.36%
Citadel Advisors LLC
382,051US$368.7k0%no data
0.34%
Bernd Seizinger
366,991US$354.1k0%no data
0.3%
Marshall Wace LLP
323,982US$312.6k0%no data
0.26%
Kirk Look
275,515US$265.9k72.8%no data
0.25%
Thomas Heineman
270,686US$261.2k73.4%no data
0.24%
Seeds
258,306US$249.3k15.4%0.05%
0.19%
The Goldman Sachs Group, Inc.
208,698US$201.4k60.3%no data
0.19%
International Assets Investment Management, LLC
206,900US$199.7k0%0.01%
0.17%
Angela Holtham
183,639US$177.2k0%no data
0.099%
Quadrature Capital Limited
106,076US$102.4k0%no data
0.098%
Allison Hagerman
105,059US$101.4k50.4%no data
0.079%
Deborah Brown
84,851US$81.9k0%no data
0.069%
Jared Kelly
73,900US$71.3k0%no data
0.065%
Franklin Resources, Inc.
69,842US$67.4k10.4%no data
0.063%
RBC Dominion Securities Inc.
68,233US$65.8k16.6%no data
0.062%
Geode Capital Management, LLC
66,939US$64.6k0%no data
0.056%
Canadian Imperial Bank of Commerce
60,381US$58.3k0%no data
0.048%
LPL Financial LLC
51,355US$49.6k0%no data
0.047%
Christophe Degois
50,670US$48.9k0%no data
0.042%
HeadInvest, LLC
44,700US$43.1k-0.3%0.01%
0.04%
Jonathan M. Rigby
42,728US$41.2k0%no data
0.04%
Patricia S. Andrews
42,728US$41.2k0%no data
0.037%
Highlands Residual Corporation
40,000US$38.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/06 13:00
End of Day Share Price 2026/01/05 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Oncolytics Biotech Inc. is covered by 18 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Douglas LoeCantor Fitzgerald Canada Corporation
Wang ChongEdison Investment Research
Patrick TrucchioH.C. Wainwright & Co.